Document is current
Any future updates will be listed below
-
Authors
Armero-Gimenez, Jorge
Schleusner, Janis
Wilbers, Ruud H. P.
Schots, Arjen
Spiga, Livia
Tregoning, John S.
Brown, Jonathan C.
Zhou, Jie
Juergens, Hannes
Finnern, Ricarda
Williams, Charles
-
Funding
Funding for this research was provided by:
Horizon 2020 (881025)
EU4Health HERA (101203358)
- License Information
-
More Information
Article History
Received: 10 October 2025
Accepted: 23 March 2026
First Online: 8 April 2026
Competing interests
: J.A-G, J.S., R.F., H.J., and C.W. were employed by LenioBio GmbH at the time of their contributions. R.F. was also a stakeholder in the company. In vivo mouse challenge studies of L.S. and J.T. were funded by LenioBio GmbH as contract research. J.A.-G. is the inventor of the patent “A system and method for cell-free unnatural amino acid incorporation” (WO2025176699A1), currently pending approval. The remaining authors declare no competing financial or non-financial interests.
